ArticleFrontiers in cell and developmental biology2026
Radiofrequency technology as an anti-aging intervention: clinical efficacy in reversing senescence-driven skin laxity and age-related dermal degeneration.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare the clinical anti-aging efficacy of multipolar radiofrequency technology and monopolar radiofrequency technology in reversing senescence-driven skin laxity and age-related dermal degeneration, and to provide scientific evidence for the selection of optimal radiofrequency anti-aging treatment protocols in aging patients. Methods: A retrospective analysis was conducted on the clinical data of 84 aging patients exhibiting senescence-associated skin laxity and age-related dermal extracellular matrix degeneration, who received radiofrequency anti-aging treatment at our hospital from January 2022 to January 2024. Patients were divided into a study group (multipolar radiofrequency treatment, n = 42) and a control group (monopolar radiofrequency treatment, n = 42) according to the treatment method. Both groups received 5 treatments, once every 2-3 weeks. Skin elasticity parameters (R2, R5, R7) - reflecting collagen and elastin fiber degradation-were measured using a cutometric device, aesthetic improvement was evaluated using GAIS, skin texture was assessed using a three-dimensional skin analyzer, and patient satisfaction was evaluated using VAS and PSES. Results: Senescence-associated skin elasticity parameters reflecting age-related dermal structural decline improved significantly in both groups at all follow-up time points compared to aging pre-treatment baseline (P < 0.05), confirming that both radiofrequency modalities can partially reverse senescence-driven dermal deterioration. At 3 months post-treatment, the improvement rates of aging biomarker parameters R2, R5, and R7 in the study group were 32.7% ± 5.2%, 28.9% ± 4.6%, and 30.8% ± 5.1%, respectively-representing substantially greater reversal of age-related elasticity decline-compared to 21.5% ± 4.1%, 18.7% ± 3.9%, and 20.1% ± 4.0% in the control group (P < 0.001). Anti-aging GAIS scores were higher in the study group at all follow-up time points (P < 0.001). Age-related skin texture deterioration showed superior improvement in the study group across senescence-associated skin roughness index, age-enlarged pore area and density, aging fine line depth, and texture uniformity (P < 0.001). VAS and PSES scores reflecting patient-perceived aging reversal were higher in the study group at all time points (P < 0.001). At 12-month follow-up, 90.5% of study group patients maintained effective anti-aging improvement versus 57.1% in the control group (P < 0.001), demonstrating superior durability of senescence-reversal. No significant difference in adverse reaction incidence between groups (P > 0.05). Conclusion: Multipolar radiofrequency technology is superior to monopolar radiofrequency technology in reversing skin laxity and dermal degeneration associated with aging, demonstrating greater improvements in skin elasticity parameters, overall aesthetic outcomes, patient satisfaction, and treatment durability, with a comparable safety profile, making it the preferred option for non-invasive skin tightening in older patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.